XOFIGO sol inj 6600 kBq/6ml vial 6 ml
7680627320014
CH-62732
V10XX03
17.02.
Reimbursement limitations:
XOFIGO4
XOFIGO est remboursé chez les patients atteints de cancer de la prostate résistant à la …
1 / 3
google
Details
- Product number
- 6273201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- radii(223-Ra) dichloridum zum Kalibrierungszeitpunkt 6600 kBq, natrii chloridum, natrii citras dihydricus, acidum hydrochloridum, aqua ad iniectabile, q.s. ad solutionem pro 6 ml corresp. natrium 26.4 mg.
Articles (1)
Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6600.0 KBQ | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
26.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5276.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2014
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 62732
- Drug name
- Xofigo, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- V10XX03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/08/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 17.02.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XOFIGO sol inj 6600 kBq/6ml vial 6 ml
- Description (DE)
- XOFIGO Inj Lös 6600 kBq/6ml Vial 6 ml
- Market launch
- 29/08/2014
- Narcotic (BTM)
- No